← Back to patent-cliff list
Salicylanilide/Methyl Salicylate/Borneol
Tier C — Watch / tradeSalicylanilide/Methyl Salicylate/Borneol
-
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：头癣, Tinea, 足癣
Regional status
US
-
EU
-
China
Approved
1996-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Salicylanilide/Methyl Salicylate/Borneol?
Approved indications include: 头癣, Tinea, 足癣.
When does the Salicylanilide/Methyl Salicylate/Borneol patent expire?
No public expiry year is available for Salicylanilide/Methyl Salicylate/Borneol yet; this page updates once verified.
How do I get a quote for Salicylanilide/Methyl Salicylate/Borneol intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-04